3-Fluorobenzodiazepines
AssigneeMerck Patent Gesellschaft mit beschraenkter Haftung
InventorsEike Poetsch, Jurgen Uhl, Dieter Marx, Wighard Strehlow, Helmut Muller-Calgan, Giuliano Dolce
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Patent Gesellschaft mit beschraenkter Haftung
InventorsEike Poetsch, Jurgen Uhl, Dieter Marx, Wighard Strehlow, Helmut Muller-Calgan, Giuliano Dolce
Estimating the term…
3-Fluoro-2,3-dihydro-1H-1,4-benzodiazepin-2-ones of the formula ##STR1## wherein R.sup.1 is H, alkyl or fluorinated alkyl of 1-4 carbon atoms and up to 9 fluorine atoms or cycloalkylalkyl of 4-8 carbon atoms; R.sup.2 is phenyl; monohalophenyl or pyridyl; R.sup.3 is F, Cl, Br or NO.sub.2, and physiologically acceptable acid addition salts thereof, are central nervous system depressants.
A 3-fluorobenzodiazepine of the formula ##STR12## wherein R.sup.1 is H, alkyl or fluorinated alkyl of 1-4 carbon atoms and up to 9 fluorine atoms or cycloalkylalkyl of 4-8 carbon atoms;
A compound of the formula:
A compound of the formula ##STR14## wherein R.sub.1 is hydrogen, alkyl having 1 to 4 carbon atoms or --CH.sub.2 CF.sub.3 ;
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
Substituted in position 2 by nitrogen, oxygen or sulfur atoms: oxygen atoms
Heterocyclic compounds
Term ended 4 Nov 1997 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
The invention relates to novel 3-fluoro-2,3-dihydro-1H-1,4-benzodiazepin-2-ones.
Structurally similar compounds which are unsubstituted by a fluorine atom in the 3-position, for example, 1-methyl-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one (diazepam) and 3-chlorodiazepam, are known.
In one composition aspect, this invention relates to 3-fluoro-2,3-dihydro-1H-1,4-benzodiazepin-2-ones of the formula ##STR2## wherein R.sup.1 is H, alkyl or fluorinated alkyl of 1-4 carbon atoms and up to 9 fluorine atoms or cycloalkylalkyl of 4-8 carbon atoms; R.sup.2 is phenyl, monohalophenyl or pyridyl; R.sup.3 is F, Cl, Br or NO.sub.2, and physiologically acceptable acid addition salts thereof.
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
20 ml. of benzene are added, under nitrogen, to a mixture of 0.1 mole of n-butyl lithium in 20 ml. of hexane and 10 g. of diisopropylamine are added dropwise at 0.degree.. A solution of 28.5 g. of 1-methyl-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one (diazepam) in 800 ml. of benzene is then added. After stirring for 1 hour at about 20.degree., the mixture is evaporated and the residue is taken up in 300 ml. of THF and a solution of 22 g. ClO.sub.3 F in 60 ml. of THF is added dropwise. After stirring for 2 hours, the mixture is evaporated and worked up in the customary manner. The product is 1-methyl-3-fluoro-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one (3-fluorodiazepam), m.p. 152.degree.-154.degree..
The following are obtained by the method of Example 1 from the corresponding compounds of Formula II (X is H):